Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 21;3(1):e9.
doi: 10.4081/cp.2013.e9. eCollection 2013 Jan 25.

Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations

Sachin Khandelwal  1 , Poras Chaudhary  1 , Dev Datta Poddar  1 , Neeraj Saxena  1 , Rana A K Singh  1 , Upendra C Biswal  1
Affiliations

Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations

Sachin Khandelwal et al. Clin Pract. .

Abstract

THIS STUDY AIMS TO COMPARE THE EFFICACY OF ANTISEPTIC DRESSINGS, HYPERBARIC OXYGEN THERAPY, AND RECOMBINANT HUMAN PLATELET DERIVED GROWTH FACTOR (RHPDGF) FOR TWO REASONS: i) to reduce the incidence of lower limb amputations in diabetic foot ulcer; ii) to limit the duration of stay in the hospital. A prospective randomized trial was conducted on 60 patients with stage III and IV diabetic foot ulcers (International Association of Enterostomal Therapy classification) and patients were divided randomly in three different therapy groups - antiseptics, hyperbaric oxygen therapy, recombinant platelet derived growth factor, with 20 patients in each group. Patients were managed initially on inpatient and then on outpatient basis till the ulcer healed completely. Results among three groups were compared using unpaired T test and the level of significance was set at P<0.05 using ANOVA. This study compares the efficacy of hyperbaric oxygen therapy, antiseptic dressings, and rhPDGF in grade III and IV diabetic foot ulcers. P value (0.0348) was significant for complete wound contraction while p value healing time (0.6534) and ulcer size (0.0593) in the groups was not significant. PDGF is safe, effective and easy to apply. Results are comparable with hyperbaric oxygen (HBO) therapy and cost of treatment is lower than other therapies. Diabetic foot ulcer management requires multidisciplinary and aggressive approach. PDGF should be recommended for all grade III and IV diabetic foot ulcer at least 8 weeks old. HBO is equally good an option but has limitations and side effects.

Keywords: antiseptic dressing; diabetic foot ulcers; hyperbaric oxygen therapy; platelet derived growth factor gel.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests: the authors declare no potential conflict of interests.

Figures

Figure 1.
Figure 1.
Patients (%) with complete healing.
Figure 2.
Figure 2.
Mean ulcer healing time (weeks).
Figure 3.
Figure 3.
Mean ulcer size (cm).
See this image and copyright information in PMC

References

    1. Lavery LA, Ashry HR, Van Houtom W, et al. Variation in the incidence and proportions of diabetes related amputations in minorities. Diabetes Care 1996;19:48-52 - PubMed
    1. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America. 2nd Ed.Bethesda, MD: National Diabetes Data Group, National Institutes of Health; 1995. NIH Publication pp409-429
    1. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation - basis for prevention. Diabetes Care 1990;13:513-21 - PubMed
    1. De Sonnaville JJJ, Colly LP, Wijkel D, Heine RJ. The prevalence and determinants of foot ulceration in type 2 diabetic patients in and primary health setting. Diabetes Res Clin Pract 1997;35:149-56 - PubMed
    1. Kumar S, Ashe HA, Parnell LN. The prevalence of foot ulceration and its correlates in type 2 diabetic patient: a population based study. Diabetic Med 1994;11:480-84 - PubMed

LinkOut - more resources